Introduction. The status of msp1, msp2 and glurp allele frequency and the diversity of Plasmodium falciparum in Northwestern Colombia before the implementation of an artemisinin-combined therapy have been explored only by a few authors and in a relatively small number of samples from this highly endemic region. Objective. To evaluate the frequency of msp1, msp2, and glurp alleles and the diversity of P. falciparum in two Colombian regions before the use of an artemisinin-combined therapy. Methods. This study was part of a major anti-malarial efficacy trial designed as a random, clinically-controlled study for which 224 subjects were recruited. Region 2 of msp1 and msp2 (central region) were amplified by a nested PCR; glurp (region R2) was ...
La resistencia de Plasmodium falciparum a la Sulfadoxina – Pirimetamina (SP) está ampliamente distri...
BACKGROUND: The efficacy of anti-malarial drugs is assessed over a period of 28-63 days (depending o...
The efficacy of anti-malarial drugs is assessed over a period of 28-63 days (depending on the drugs'...
Introduction. The status of msp1, msp2 and glurp allele frequency and the diversity of Plasmodium f...
Introduction. The genetic diversity of Plasmodium falciparum has been one of the major obstacles for...
Introduction: Surveillance of the genetic characteristics of dhps and dhfr can be useful to outline ...
Introduction. Plasmodium falciparum is a highly polymorphic parasite, which allows it to evade the h...
Abstract. The merozoite surface protein 1 (MSP-1) gene of Plasmodium falciparum encodes a major immu...
This work was supported by POM/PEF/ Instituto Oswaldo Cruz, PAPES-Fiocruz, and CNPq-PRONEX/DECIT/FAP...
Introduction. Resistance of Plasmodium falciparum to different antimalarial drugs is an obstacle to ...
Introduction. Studies on the molecular epidemiology of antimalarial resistance constitute a useful t...
La aparición de la resistencia a los antimaláricos ha sido un gran problema para controlar la malari...
Genetic diversity provides Plasmodium falciparum with the potential capacity of avoiding the immune ...
Abstract: Colombian field isolates of Plasmodium falciparum were analyzed for genetic diversity. Fif...
Abstract Background In this first study conducted after the introduction of artemisinin-combination ...
La resistencia de Plasmodium falciparum a la Sulfadoxina – Pirimetamina (SP) está ampliamente distri...
BACKGROUND: The efficacy of anti-malarial drugs is assessed over a period of 28-63 days (depending o...
The efficacy of anti-malarial drugs is assessed over a period of 28-63 days (depending on the drugs'...
Introduction. The status of msp1, msp2 and glurp allele frequency and the diversity of Plasmodium f...
Introduction. The genetic diversity of Plasmodium falciparum has been one of the major obstacles for...
Introduction: Surveillance of the genetic characteristics of dhps and dhfr can be useful to outline ...
Introduction. Plasmodium falciparum is a highly polymorphic parasite, which allows it to evade the h...
Abstract. The merozoite surface protein 1 (MSP-1) gene of Plasmodium falciparum encodes a major immu...
This work was supported by POM/PEF/ Instituto Oswaldo Cruz, PAPES-Fiocruz, and CNPq-PRONEX/DECIT/FAP...
Introduction. Resistance of Plasmodium falciparum to different antimalarial drugs is an obstacle to ...
Introduction. Studies on the molecular epidemiology of antimalarial resistance constitute a useful t...
La aparición de la resistencia a los antimaláricos ha sido un gran problema para controlar la malari...
Genetic diversity provides Plasmodium falciparum with the potential capacity of avoiding the immune ...
Abstract: Colombian field isolates of Plasmodium falciparum were analyzed for genetic diversity. Fif...
Abstract Background In this first study conducted after the introduction of artemisinin-combination ...
La resistencia de Plasmodium falciparum a la Sulfadoxina – Pirimetamina (SP) está ampliamente distri...
BACKGROUND: The efficacy of anti-malarial drugs is assessed over a period of 28-63 days (depending o...
The efficacy of anti-malarial drugs is assessed over a period of 28-63 days (depending on the drugs'...